Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMS MAXIMS is a leading provider of healthcare information systems, specializing in Electronic Patient Record (EPR) and Patient Administration Systems (PAS) for the UK and Irish markets. The company's flagship product, MAXIMS, is an open-standard clinical software platform designed to improve patient safety and clinical outcomes by providing real-time access to patient data. Their solutions support a wide range of healthcare settings, including acute care, mental health, and community services. In 2022, the company was acquired by Harris Computer, a subsidiary of Constellation Software, to expand its healthcare IT portfolio and enhance its service delivery to the NHS and other healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMS Maxims.